A citation-based method for searching scientific literature

Anetta Undas, Ilona Wiek, Ewa Stêpien, Krzysztof Zmudka, Wieslawa Tracz. Diabetes Care 2008
Times Cited: 115







List of co-cited articles
800 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.
J P Collet, Y Allali, C Lesty, M L Tanguy, J Silvain, A Ankri, B Blanchet, R Dumaine, J Gianetti, L Payot,[...]. Arterioscler Thromb Vasc Biol 2006
245
12

The influence of type 2 diabetes on fibrin structure and function.
E J Dunn, R A S Ariëns, P J Grant. Diabetologia 2005
136
12

Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease.
Joseph D Mills, Robert A S Ariëns, Michael W Mansfield, Peter J Grant. Circulation 2002
157
12

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Mikhail Kosiborod, Saif S Rathore, Silvio E Inzucchi, Frederick A Masoudi, Yongfei Wang, Edward P Havranek, Harlan M Krumholz. Circulation 2005
433
11

Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.
Katsuomi Iwakura, Hiroshi Ito, Masashi Ikushima, Shigeo Kawano, Atsushi Okamura, Katsuaki Asano, Tadashi Kuroda, Koji Tanaka, Tohru Masuyama, Masatsugu Hori,[...]. J Am Coll Cardiol 2003
289
11


Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress.
Anetta Undas, Konstanty Szułdrzynski, Ewa Stepien, Jarosław Zalewski, Jacek Godlewski, Wiesława Tracz, Mieczysław Pasowicz, Krzysztof Zmudka. Atherosclerosis 2008
139
11

Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.
Anetta Undas, Krystyna Zawilska, Mariola Ciesla-Dul, Agata Lehmann-Kopydłowska, Agnieszka Skubiszak, Katarzyna Ciepłuch, Wiesława Tracz. Blood 2009
194
11


Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke.
Anetta Undas, Piotr Podolec, Krystyna Zawilska, Monika Pieculewicz, Ireneusz Jedliński, Ewa Stepień, Ewa Konarska-Kuszewska, Przemysław Weglarz, Malłgorzata Duszyńska, Ewelina Hanschke,[...]. Stroke 2009
108
10

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
Ischa Stranders, Michaela Diamant, Rogier E van Gelder, Hugo J Spruijt, Jos W R Twisk, Robert J Heine, Frans C Visser. Arch Intern Med 2004
252
10

Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.
Vijender R Vaidyula, A Koneti Rao, Maria Mozzoli, Carol Homko, Peter Cheung, Guenther Boden. Diabetes 2006
129
10

Coagulation and fibrinolysis in diabetes.
S H Alzahrani, R A Ajjan. Diab Vasc Dis Res 2010
142
10

Platelet dysfunction in type 2 diabetes.
A I Vinik, T Erbas, T S Park, R Nolan, G L Pittenger. Diabetes Care 2001
380
10

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Prakash Deedwania, Mikhail Kosiborod, Eugene Barrett, Antonio Ceriello, William Isley, Theodore Mazzone, Philip Raskin. Circulation 2008
311
9

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, Jose C Nicolau, Judith S Hochman, W Douglas Weaver, Pierre Theroux, Gustavo B F Oliveira, Thomas G Todaro, Christopher F Mojcik,[...]. Eur Heart J 2006
141
9

Platelet activation in type 2 diabetes mellitus.
P Ferroni, S Basili, A Falco, G Davì. J Thromb Haemost 2004
301
9

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
K Malmberg, L Rydén, H Wedel, K Birkeland, A Bootsma, K Dickstein, S Efendic, M Fisher, A Hamsten, J Herlitz,[...]. Eur Heart J 2005
709
9


Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
Ramzi A Ajjan, Toby Gamlen, Kristina F Standeven, Salihah Mughal, Katharina Hess, Kerrie A Smith, Emma J Dunn, M Maqsud Anwar, Naila Rabbani, Paul J Thornalley,[...]. Blood 2013
54
16

Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.
Marlien Pieters, Namukolo Covic, Francois H van der Westhuizen, Chandrasekaran Nagaswami, Yelena Baras, Du Toit Loots, Johann C Jerling, Dale Elgar, Kathryn S Edmondson, Danie G van Zyl,[...]. Thromb Haemost 2008
46
17

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.
Anna Norhammar, Ake Tenerz, Göran Nilsson, Anders Hamsten, Suad Efendíc, Lars Rydén, Klas Malmberg. Lancet 2002
760
8

Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system.
R A Ajjan, K F Standeven, M Khanbhai, F Phoenix, K C Gersh, J W Weisel, M T Kearney, R A S Ariëns, P J Grant. Arterioscler Thromb Vasc Biol 2009
81
9

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Stephen D Wiviott, Eugene Braunwald, Dominick J Angiolillo, Simha Meisel, Anthony J Dalby, Freek W A Verheugt, Shaun G Goodman, Ramon Corbalan, Drew A Purdy, Sabina A Murphy,[...]. Circulation 2008
526
8

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
8

Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction.
Jorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, Jan-Henk E Dambrink, Jan C A Hoorntje, A T Marcel Gosselink, Harry Suryapranata, Felix Zijlstra, Arnoud W J van 't Hof. J Am Coll Cardiol 2005
105
8

Hyperglycemia: a prothrombotic factor?
B A Lemkes, J Hermanides, J H Devries, F Holleman, J C M Meijers, J B L Hoekstra. J Thromb Haemost 2010
145
8

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk, Hans Erik Bøtker, Won Yong Kim, Anders B Mathiasen, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Peter Clemmensen,[...]. Eur Heart J 2012
387
8

Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.
J P Collet, D Park, C Lesty, J Soria, C Soria, G Montalescot, J W Weisel. Arterioscler Thromb Vasc Biol 2000
339
7

Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
Angela M Carter, Charlotte M Cymbalista, Tim D Spector, Peter J Grant. Arterioscler Thromb Vasc Biol 2007
122
7

Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
Anetta Undas, Agnieszka Slowik, Pawel Wolkow, Andrzej Szczudlik, Wiesława Tracz. Thromb Res 2010
71
9

Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects.
Vijender R Vaidyula, Guenther Boden, A Koneti Rao. Platelets 2006
67
10

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.
Katherine Esposito, Francesco Nappo, Raffaele Marfella, Giovanni Giugliano, Francesco Giugliano, Myriam Ciotola, Lisa Quagliaro, Antonio Ceriello, Dario Giugliano. Circulation 2002
7

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
Mikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, Lan Xiao, Philip G Jones, Suzanne Fiske, Frederick A Masoudi, Steven P Marso, John A Spertus. Circulation 2008
284
7

Altered properties of the fibrin gel structure in patients with IDDM.
G Jörneskog, N Egberg, B Fagrell, K Fatah, B Hessel, H Johnsson, K Brismar, M Blombäck. Diabetologia 1996
72
9

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Stefan James, Dominick J Angiolillo, Jan H Cornel, David Erlinge, Steen Husted, Frederic Kontny, Juan Maya, Josë C Nicolau, Jindrich Spinar, Robert F Storey,[...]. Eur Heart J 2010
284
7

Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
G Anfossi, E M Mularoni, S Burzacca, M C Ponziani, P Massucco, L Mattiello, F Cavalot, M Trovati. Diabetes Care 1998
91
7

Composition of coronary thrombus in acute myocardial infarction.
Johanne Silvain, Jean-Philippe Collet, Chandrasekaran Nagaswami, Farzin Beygui, Kathryn E Edmondson, Anne Bellemain-Appaix, Guillaume Cayla, Ana Pena, Delphine Brugier, Olivier Barthelemy,[...]. J Am Coll Cardiol 2011
238
7


Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
Guenther Boden, Vijender R Vaidyula, Carol Homko, Peter Cheung, A Koneti Rao. J Clin Endocrinol Metab 2007
97
7

Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents.
B B Dokken, L R La Bonte, G Davis-Gorman, M K Teachey, N Seaver, P F McDonagh. Horm Metab Res 2011
46
15



Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
J Y Park, N Takahara, A Gabriele, E Chou, K Naruse, K Suzuma, T Yamauchi, S W Ha, M Meier, C J Rhodes,[...]. Diabetes 2000
214
7

Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Anetta Undas, Jan Brozek, Milosz Jankowski, Zbigniew Siudak, Andrew Szczeklik, Hieronim Jakubowski. Arterioscler Thromb Vasc Biol 2006
92
6

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
Joshua A Beckman, Mark A Creager, Peter Libby. JAMA 2002
6

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
6

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Deepak L Bhatt, Keith A A Fox, Werner Hacke, Peter B Berger, Henry R Black, William E Boden, Patrice Cacoub, Eric A Cohen, Mark A Creager, J Donald Easton,[...]. N Engl J Med 2006
6

Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age.
K Fatah, A Silveira, P Tornvall, F Karpe, M Blombäck, A Hamsten. Thromb Haemost 1996
180
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.